Capnia, Inc. (NASDAQ:SLNO) received a $25.00 price objective from analysts at Maxim Group in a note issued to investors on Thursday. The firm currently has a “buy” rating on the stock.

Separately, ValuEngine raised Capnia from a “strong sell” rating to a “sell” rating in a research note on Friday, October 6th.

Capnia (NASDAQ SLNO) traded down 0.39% during trading on Thursday, reaching $2.56. The company’s stock had a trading volume of 62,358 shares. Capnia has a 52-week low of $0.49 and a 52-week high of $6.60. The stock’s market cap is $24.54 million. The firm has a 50 day moving average price of $2.75 and a 200-day moving average price of $2.86.

Capnia (NASDAQ:SLNO) last announced its earnings results on Friday, August 11th. The company reported ($0.30) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.40) by $0.10. Capnia had a negative return on equity of 69.67% and a negative net margin of 1,389.76%. On average, analysts expect that Capnia will post ($1.35) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/12/maxim-group-reiterates-25-00-price-target-for-capnia-inc-slno.html.

Capnia Company Profile

Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.